School of Breast Oncology® Online Curriculum

School of Breast Oncology® Online Curriculum is organized by Physicians' Education Resource, LLC (PER).

Release Date: January 31, 2020
Expiration Date: January 31, 2021

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 26.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 26.0 Contact Hours.

Activity Overview:
An increasing number of oncologists are focusing their clinical practices on the treatment of breast cancer, creating a need for specialized education. The School of Breast Oncology®, which has been held annually since 2003, was developed to advance patient care by providing a curriculum-based program focused exclusively on breast cancer clinical management. This intensive 3-day interactive program provides a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention, and treatment, with lectures emphasizing the clinical implications presented by leading clinical investigators. The School of Breast Oncology® both provides a comprehensive overview for fellows or oncologists who are new to practice and serves as a valuable refresher course, with updates on the latest data and changes to standards of care for oncologists who have been in practice for several years or more. This online activity captures all of the lectures presented at the live 2019 School of Breast Oncology®, organizes them in a convenient modular format, and summarizes the existing data for each topic, with an emphasis on the evidence-based foundations for optimal, individualized decision making in the clinic.

Benefits of Participating:
• Gain insights into using biologic subtype as well as predictive and prognostic biomarkers for treatment selection
• Recognize factors that increase the risk of breast cancer development and adopt strategies for risk reduction in high-risk women
• Learn to utilize and interpret results from breast imaging modalities
Review the latest innovations in locoregional control, including surgical and radiation advances
• Outline tactics for individualizing (neo)adjuvant therapy for early-stage and locally advanced breast cancers based on breast cancer subtype and recurrence risk
• Integrate novel agents into treatment algorithms for metastatic disease based on expert guidelines and emerging clinical evidence
• Improve recognition and management of adverse events associated with newer treatment options
Apply the latest evidence, therapies, and strategies in your breast cancer practice

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Review breast cancer biology, molecular subtyping, staging, and prognostic and/or predictive biomarkers, in order to better individualize therapy and counsel patients regarding conventional and investigational treatment options
• Integrate genomic and molecular biomarkers, and gene expression assays, into treatment planning to optimize outcomes for patients with breast cancer
• Discuss the application of current and evolving imaging options for diagnosing, staging, and monitoring breast cancer
• Incorporate current guidelines and evolving evidence with regard to local treatment options, including advances in surgery and radiation therapy, into the management of patients with breast cancer
• Individualize selection of systemic therapies for patients with early-stage or advanced/metastatic breast cancer by taking into consideration efficacy and safety data, expert guidelines, patient characteristics and co-morbidities, and genomic and/or molecular tumor information
• Evaluate emerging clinical data and evolving strategies for the treatment of breast cancer, and apply clinical trial data appropriately in order to optimize outcomes for individual patients
• Utilize supportive care strategies for preventing and managing treatment-related adverse events in patients receiving therapy for breast cancer
• Facilitate awareness of clinical trial opportunities based on knowledge of emerging approaches and variances in care in the field of breast cancer management